Lv11
90 积分 2026-01-29 加入
PD-1 blockade unleashes local hepatitis B virus-related B cell response inhibiting hepatocellular carcinoma
1个月前
已完结
Altered intestinal Streptococcus anginosus and 5α-reductase gene levels in patients with hepatocellular carcinoma and elevated Bacteroides stercoris in atezolizumab/bevacizumab non-responders
1个月前
已完结
Identification of MAGE-A10 specific T cell receptor promising in immunotherapy of hepatocellular carcinoma
1个月前
已完结
Gut microbiome in metabolic dysfunction-associated steatotic liver disease and associated hepatocellular carcinoma
1个月前
已完结
Nanomedicines for reversing immunosuppressive microenvironment of hepatocellular carcinoma
1个月前
已完结
The Efficacy and Safety of TACE or HAIC Combined With ICIs and Angiogenesis Inhibitors in Unresectable Hepatocellular Carcinoma
1个月前
已完结
The clinical implications of trial endpoints in immunotherapy for hepatocellular carcinoma
1个月前
已完结
Outcomes and safety of atezolizumab plus bevacizumab in the treatment of hepatocellular carcinoma: treatment prognosis and comparison with tyrosine kinase inhibitors in a French multicenter matched real-life study
1个月前
已完结
Activation of Wnt/β-catenin signaling promotes immune evasion via the β-catenin/IKZF1/CCL5 axis in hepatocellular carcinoma
1个月前
已完结
An etiology-stratified single-cell atlas identifies FABP4 as a prognostic marker for MASLD-related HCC
1个月前
已完结
皖公网安备34019202002308
